Newsfeeds Archive - Page 2 of 45

2 minute read

AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion

May 21, 7:16 AM

AstraZeneca aims to boost its revenue from $45.8 billion in 2023 to $80 billion by 2030. Key growth drivers include expanding oncology, biopharmaceuticals, rare disease portfolios, and launching 20 new medicines.

AZN

1 minute read

Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population

By Vandana Singh

May 20, 2:38 PM

Amgen and AstraZeneca reveal Phase 2a results for Tezspire in severe COPD, showing a 17% reduction in exacerbations, with notable improvements in lung function and quality of life for patients with higher blood eosinophil counts.

AMGN

2 minute read

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute

By Vandana Singh

May 20, 2:18 PM

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.

AZN

1 minute read

News

Reported Sunday, AstraZeneca And Amgen’s TEZSPIRE Shows Potential For Future Chronic Obstructive Pulmonary Diseasetreatment In New Data Presented At ATS 2024

By Benzinga Newsdesk

May 20, 12:55 AM

Late-breaking results from the Phase IIa COURSE trial provide insight into TEZSPIRE's impact on COPD exacerbations in patients with a broad range of eosinophil levels The Phase IIa COURSE trial was a

AMGN

1 minute read

AstraZeneca’s COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity, Data Shows

By Vandana Singh

May 16, 11:34 AM

AstraZeneca's Phase 3 SUPERNOVA trial shows sipavibart significantly reduces symptomatic COVID-19 in immunocompromised patients. The trial met primary endpoints, showing effectiveness against various SARS-CoV-2 variants.

AZN

3 minute read

Penny Stocks

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe’s Pharma Game

By Upwallstreet

May 16, 8:51 AM

On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, just ahead of this year’s “Choose Franc

ABB

1 minute read

Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France’s Healthcare Sector

By Vandana Singh

May 13, 11:36 AM

Pfizer and AstraZeneca invest over $1 billion in France's healthcare sector, bolstering R&D capabilities and job creation.

AZN

2 minute read

Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2

By Avi Kapoor

May 9, 8:44 AM

As of May 9, 2024, five stocks in the health care sector could be flashing a real warning…

AZN

1 minute read

Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: ‘Digital Medicine With Incredible Potential’

By Shanthi Rexaline

May 9, 5:01 AM

Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists.

ARCT

2 minute read

AstraZeneca Pulls Plug On Vaxzevria COVID-19 Vaccine Amid Surplus of Updated Vaccines

By Benzinga Neuro

May 8, 6:23 AM

It is worth noting that AstraZeneca has previously conceded in court documents that Vaxzevria can induce side effects such as blood clots and low blood platelet counts.

AZN